Discovery of Novel Isothiazole, 1,2,3-Thiadiazole, and Thiazole-Based Cinnamamides as Fungicidal Candidates.
Clicks: 236
ID: 64096
2019
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Popular Article
30.0
/100
235 views
14 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
A series of isothiazole, 1,2,3-thiadiazole, and thiazole-based cinnamamide morpholine derivatives were rationally designed, synthesized, characterized, and evaluated for their fungicidal activities. Bioassay indicated that a combination of 3,4-dichloroisothiazole active substructures with cinnamamide morpholine lead to significant improvement of in vivo antifungal activities of the target compounds; among them, compound exhibited good fungicidal activity against in vivo with an inhibition rate of 100% at 100 μg/mL. A field experiment indicated that the difference of efficacy between (75.9%) and dimethomorph (77.1%) at 37.5 g ai/667 m was not significant; and also exhibited good activity against by triggering accumulation of and defense-related gene expression and the defense associated enzyme phenylalanine ammonia-lyase (PAL) expression on cucumber, rather than direct inhibition. These findings strongly supported that 3,4-dichloroisothiazole containing cinnamamide morpholine not only showed good fungicidal activity against but also exhibited plant innate immunity stimulation activity as a promising fungicide candidate with both fungicidal activity and systemic acquired resistance.
| Reference Key |
chen2019discoveryjournal
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Chen, Lai;Zhao, Bin;Fan, Zhijin;Hu, Mengxu;Li, Qing;Hu, Wenhao;Li, Jiwei;Zhang, Jinlin; |
| Journal | Journal of agricultural and food chemistry |
| Year | 2019 |
| DOI |
10.1021/acs.jafc.9b03891
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.